article21 April 2021 | By Abhishek Kumar, Anthony Barron, Eva Marchese PhD, Kees Chamberlain
In this article, Charles River Associates (CRA) delves into why traditional vaccine procurement schemes are not fit for purpose during the pandemic and how both governments and manufacturers must adapt to manage the greater level of risk associated with pandemic vaccine development and distribution.